NCI AWARDS $25 MILLION FOR PATIENT NAVIGATOR RESEARCH PROGRAM FOR MINORITY AND UNDERSERVED CANCER PATIENTS

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



U.S. Department of Health and Human Services 
NATIONAL INSTITUTES OF HEALTH 
NIH News 
National Cancer Institute (NCI) 
http://www.cancer.gov/

FOR IMMEDIATE RELEASE: Thursday, October 27, 2005 

CONTACT: NCI Media Relations Branch, 301-496-6641,
ncipressofficers@xxxxxxxxxxxx 
 
NCI AWARDS $25 MILLION FOR PATIENT NAVIGATOR RESEARCH PROGRAM FOR
MINORITY AND UNDERSERVED CANCER PATIENTS 

The National Cancer Institute (NCI) today announced a total of $25
million in grants to eight research institutions to develop an
innovative Patient Navigator Research Program (PNRP). Navigators help
patients and their families manage cancer diagnoses and overcome common
barriers to obtaining timely and appropriate cancer care and treatment.
The five-year grants will be administered by NCI's Center to Reduce
Cancer Health Disparities (CRCHD). 

"Studying various forms of patient navigation is extremely important,"
said Mark Clanton, M.D., NCI deputy director for cancer care delivery
systems. "This area of research can help us take a huge step toward
narrowing cancer health disparities and ensuring that knowledge,
advancements, and technology are shared with patients in all
communities." 

Patient navigators help coordinate services among medical personnel,
schedule appointments with caregivers, arrange translation or
interpretation services and various forms of financial support,
facilitate transportation to and from medical visits, and arrange
childcare services during diagnosis and treatment appointments.
Navigators from primary care or community health settings provide
support and guidance, linking patients to existing health care services.


The PNRP will test and evaluate interventions designed to improve access
to timely and appropriate cancer care and treatment following a cancer
diagnosis. The new program will focus on four cancers for which
screening tests are available: breast, cervical, prostate and
colorectal. 

These grants will focus on cancer patients from racial/ethnic minority
groups, patients with low socioeconomic status, and patients from
medically underserved areas. There will be significant community input
through Community Advisory Panels (CAP). Composed of community leaders,
community-based participatory researchers, and clinicians, CAPS will
help plan partnerships to ensure support from diverse underserved
communities. 

The following eight institutions were awarded PNRP grants: 

-- Boston University Medical Center, Boston, Mass. 
Principle Investigator: Karen M. Freund, M.D. 
The Patient Navigation in the SafetyNet: CONNECTeDDTM Project will
partner with community health centers to provide either breast or
cervical cancer navigation services to women in socially and
economically challenged urban neighborhoods. 

-- Denver Health and Hospital Authority, Denver, Colo. 
Principle Investigator: Peter C. Raich, M.D.
The Improving Patient Outcomes through System Navigation Project will
work with community partners in the Rocky Mountain region, AMC Cancer
Research Center, and the University of Colorado Comprehensive Cancer
Center to provide breast, colorectal, and prostate cancer navigation
services for minority and underserved patients, many of whom do not have
health insurance. 

-- George Washington University, Washington, D.C. 
Principle Investigator: Steven Patierno, Ph.D.
The D.C. City-wide Patient Navigation Research Project will develop a
consortium comprised of major medical institutions, community partners,
and the local health department to create a city-wide initiative to test
and evaluate breast cancer navigation services among African American
and Hispanic/Latina women. 

-- H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla. 
Principle Investigator: Richard G. Roetzheim, M.D.
The Moffitt Cancer Center Patient Navigator Project will collaborate
with the Health Choice Network and its member community health centers,
and the American Cancer Society to conduct culturally appropriate
patient navigation focused on breast and colorectal cancers in
culturally diverse populations. 

-- Northwest Portland Area Indian Health Board, Portland, Ore. 
Principle Investigator: Joshua D. Jones, M.D.
The Northwest Tribal Cancer Navigator Project, in conjunction with
tribal health centers, will expand an existing navigation project in
five diverse tribal communities and provide breast, cervical, prostate
and colorectal cancer navigation services. 

-- Northwestern University, Evanston, Ill. 
Principle Investigator: Charles L. Bennett, M.D.
The Chicago Cancer Navigation Project will develop and conduct a patient
navigation intervention to provide follow-up care to low-income patients
with positive cancer screening tests of the prostate, colorectum, breast
or cervix, in collaboration with the Veterans Affairs and federally
qualified health center clinics. 

-- University of Rochester, Rochester, N.Y. 
Principle Investigator: Kevin Fiscella, M.D.
The Randomized Controlled Trial of Primary Care-Based Patient
Navigation-Activation Project, focusing on breast and colorectal
cancers, will recruit patients from large, inner-city practices, serving
primarily minority and low-income populations, to assess whether
underserved populations benefit from navigation services. 

-- University of Texas Health Sciences Center, San Antonio, Texas 
Principle Investigator: Donald J. Dudley, M.D. 
The Texas Health Science Center's Patient Navigation Research Project,
focusing on breast and cervical cancers, will develop and conduct a
navigator program primarily for Hispanic/Latina and African American
women, in collaboration with district health and university health
clinics, community-based agencies, and the university hospital.
 
"In order to meet our challenge goal to eliminate suffering and death
due to cancer, we must ensure that any patient with a suspicious finding
is provided timely diagnosis and that patients who are diagnosed with
cancer experience no delay in receiving high-quality cancer care,
regardless of their race, ethnicity, socioeconomic status or geography,"
stated Harold Freeman, M.D., senior advisor to the NCI director on
minority and underserved communities. "These projects will help improve
access to quality, standard cancer care and could contribute to
substantial progress in reducing cancer health disparities." 

In addition to the newly announced grants, NCI continues to fund patient
navigator pilot projects that reach American Indian, Hispanic/Latino,
African American and rural underserved populations. 

For additional information about the Patient Navigator Research Program
and grantees, go to: http://crchd.nci.nih.gov. 

For more information about cancer, visit the NCI Web site at
http://www.cancer.gov, or call NCI's Cancer Information Service at
1-800-4 CANCER (1-800-422-6237). 

The National Institutes of Health (NIH) -- "The Nation's Medical
Research Agency" -- includes 27 Institutes and Centers and is a
component of the U. S. Department of Health and Human Services. It is
the primary Federal agency for conducting and supporting basic,
clinical, and translational medical research, and it investigates the
causes, treatments, and cures for both common and rare diseases. For
more information about NIH and its programs, visit http://www.nih.gov.
  
##
 
This NIH News Release is available online at:
http://www.nih.gov/news/pr/oct2005/nci-27a.htm.

To subscribe (or unsubscribe) from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.

[Index of Archives]     [CDC News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux